ANRS 0146s NOVAA TEN

Yellow fever vaccination in HIV-1-infected individuals: A study of long-term immune responses

Last updated on 16 March 2026

Main points

This is a non-randomised, multicentre study comparing two parallel groups, initially comprising 40 HIV-positive subjects and 20 HIV-negative subjects.

Following the signing of the informed consent form and verification of inclusion criteria, participants in the ANRS EP46 NOVAA study are enrolled in the study:

  • 40 HIV-positive subjects enrolled in Infectious Diseases departments
  • 20 HIV-negative subjects enrolled in Travel Medicine departments

Assessment will take place at M156 (+/- 18 months), i.e. more than 10 years after vaccination.

Study type

Category 2, multicentre interventional research comparing two parallel groups of 40 HIV-positive and 20 HIV-negative subjects included in the ANRS EP46 NOVAA study.

Study objectives

To determine vaccine responses by measuring neutralising antibody titres using long-term PRNT neutralisation tests in participants of the ANRS EP46 NOVAA study, people living with HIV (PLHIV) and vaccination-naïve controls 156 months after primary yellow fever vaccination.

Note:

  • To determine vaccine responses by measuring neutralising antibody titres using AcN 400 pseudo–type neutralisation tests.
  • To identify clinical and biological factors predictive of a sustained vaccine response.

Principal Investigator
Dr Nathalie COLIN DE VERDIER

Units/teams
Centre for Methodology and Management
Prof. Laurence MEYER (Inserm)

Investigating Centres:
• Dr Nathalie Colin de Verdière, Department of Infectious Diseases, Saint Louis Hospital, Paris
• Prof. Jade Ghosn, Department of Infectious and Tropical Diseases, Bichat Claude Bernard Hospital, Paris
• Prof. Odile Launay, Vaccinology Clinical Research Centre, Cochin Hospital, Paris

Status
Recruitment in progress

Number of participants
60 (40 people living with HIV and 20 controls)

Pathology
HIV-1

Funding
Inserm – ANRS MIE

Download the study information for researchers

.pdf 1 MB

Download the study information for participants

.pdf 982 KB

You are taking part in or have taken part in this study

The information sheet above contains details of ancillary studies for which your data or samples may be or may have been reused, provided you gave your consent at the time of your enrolment.

If you would like to find out more about your participation in a clinical trial, please see the section below.

Go to the Participant platform